#Latest news with #LP8.1Reuters20-05-2025HealthReutersUS FDA advisers to consider if new COVID shots should target LP.8.1 subvariantMay 20 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether to recommend COVID-19 vaccines for 2025-26 for targetting the LP.8.1 subvariant, documents filed on Tuesday showed. The panel of advisers will make recommendations on the selection of the 2025-2026 formula for COVID-19 vaccines for use in the United States on Thursday.
Reuters20-05-2025HealthReutersUS FDA advisers to consider if new COVID shots should target LP.8.1 subvariantMay 20 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether to recommend COVID-19 vaccines for 2025-26 for targetting the LP.8.1 subvariant, documents filed on Tuesday showed. The panel of advisers will make recommendations on the selection of the 2025-2026 formula for COVID-19 vaccines for use in the United States on Thursday.
20-05-2025
